Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Astrocytoma × Neuropsychological Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 4 Neoplasms 2 Breast Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hodgkin Disease 1 Glioma 1 Glioblastoma 1 Fatigue 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Astrocytoma 1

Interventions

Temozolomide 100 Radiotherapy 53 Bevacizumab 28 Carboplatin 27 Carmustine 26 Magnetic Resonance Spectroscopy 23 Filgrastim 20 Surgical Procedures, Operative 18 Irinotecan 18 Radiation 15 Lomustine 15 Vincristine 14 Etoposide 13 Specimen Handling 11 Radiotherapy, Intensity-Modulated 11 Procarbazine 11 Peripheral Blood Stem Cell Transplantation 11 O(6)-benzylguanine 11 Cyclophosphamide 11 Erlotinib Hydrochloride 10 Chemotherapy, Adjuvant 10 sargramostim 9 Cisplatin 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Thiotepa 8 Granulocyte Colony-Stimulating Factor 8 Flucytosine 8 Everolimus 7 vocimagene amiretrorepvec 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡